ORCL has recovered 35% over the past month, but Tuesday's 3.6% pullback to $186.83 arrived just as Wedbush pushed its price target to $275 — the loudest divergence in the stock's near-term setup.
The analyst picture has tilted sharply more constructive this week. Wedbush's Daniel Ives raised his target from $225 to $275 on May 13, maintaining his Outperform rating, a day after Oppenheimer lifted its own target from $210 to $235. Both firms point to the same theme: AI infrastructure demand that Oracle's cloud division is capturing faster than the Street expected. The bull case is well-documented — cloud revenue running at $8.9 billion last quarter, up 41% year-on-year, and remaining performance obligations surging 325%, with management targeting $90 billion in FY27 revenue. Morgan Stanley holds a more sceptical position at Equal-Weight with a $207 target, trimmed from $213 in late April — a quiet acknowledgment that the valuation premium has grown harder to justify at current levels. The Street's mean target is $244, roughly 31% above Tuesday's close, ranking Oracle near the top of the software universe on analyst return potential. That skew is not subtle.
Valuation multiples reflect the re-rating. The PE has climbed to 24.4x, up nearly 4 points over the past month. The EV/EBITDA has eased to 15.6x — down 1.2x over the same period, suggesting earnings estimates have moved faster than the enterprise value. The price-to-book is 10x, up roughly a point on the month. These are not cheap multiples for a company whose EPS momentum scores in the 37th and 40th percentiles on 30- and 90-day horizons, and whose forward EPS year-on-year growth ranks in just the 25th percentile. The bull case rests on the AI infrastructure narrative being structural enough to close that gap.
Short positioning tells a quieter story, though one that's been trending in one direction. Short interest at 1.14% of the free float is not a pressure point on its own, but shorts have added steadily — up about 5% over both the past week and the past month, from roughly 30.4 million shares to 32.4 million. Borrow costs are negligible at 0.47%, and availability remains extremely loose, well in excess of 1,000% of short interest. That means there is no shortage of shares to borrow and no mechanical squeeze risk. The ORTEX short score is 29.5, a low reading, and has drifted only modestly higher across the past two weeks. This is not a stock where short sellers are making a high-conviction directional bet — the gradual build looks more like hedging against the 35% run than a structural short thesis.
Options positioning is close to neutral. The put/call ratio is 0.82, just above its 20-day average of 0.81, with a z-score near zero. The 52-week range runs from 0.57 to 1.06, so the current reading is firmly in the middle of that band. Options traders have not moved defensively into the June 8 earnings date the way they might have in a more contested setup.
Insider activity offers a partial caution. The 90-day net is a $4.2 million sell — small relative to the stock's size, but every recent disclosed transaction has been a sale, including the Chief Legal Officer selling $2.6 million worth in mid-April and the CEO selling in February. The pattern is consistent, if not alarming. Lawrence Ellison's 40% ownership stake is unchanged. Institutional holders are adding — Vanguard bought 6.6 million shares in Q1, BlackRock 8.1 million through April, and Capital Research added 3.8 million through the same period. The buying at the institutional level contrasts with the insider sell flow in a way that has defined Oracle's ownership structure for some time.
The June 8 earnings call is the next hard test. Oracle's most recent print in March produced a 7.6% one-day gain. The prior December quarter saw a 10.2% drop the next day, followed by a further 19.4% five-day decline. The pattern is lumpy, and the setup going in — a stock up 35% in a month, with the Street raising targets ahead of the print and short interest quietly building — makes the quality of the AI revenue commentary the central variable to watch.
See the live data behind this article on ORTEX.
Open ORCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
